Tandem Diabetes’ t:slim X2 Insulin Pump has received FDA approval for use alongside Dexcom’s G5 Mobile continuous glucose monitoring (CGM) technology. The approval is part of a rapid evolution ...

New research has examined how accurate continuous glucose monitors (CGM) are in comparison to capillary blood glucose ...

A recently published study highlighted the strong performance of the Insulet (Nasdaq:PODD) Omnipod 5 in children and young ...

Tandem Diabetes Care, Inc.’s TNDM fourth-quarter 2024 performance was driven by its impressive range of new products. The company’s impressive strategic initiatives provide a favorable opportunity for ...

Welcome to the era of algorithm-driven diabetes management, where closed-loop glucose monitoring systems keep you from ...

Lilly has taken a non-exclusive license to deploy Dexcom’s CGM systems – which include app-based remote monitoring and alarm functions – in pen- and pump-based insulin systems that form the ...

Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial ...

In the US, Eversense 365 is recognised as an integrated CGM (iCGM) system, capable of integrating with compatible medical devices, such as insulin pumps, for automated insulin delivery (AID ...

Key Highlights: -- Eversense 365 offers the longest-lasting CGM, staying active for an entire ... and the ability to integrate with insulin pumps for automated insulin delivery systems.